Yescarta – Oncology – Gilead Yescarta Apr Display Banners HCP Wallboard Extension – 54894

Aprospective translational study presented at the European Society of Medical Oncology (ESMO) Congress identified a differential expression of genes encoded for costimulatory molecules and cytokines between patients with...

Between ages 69 and 70, there is a decline in adjuvant therapy recommendations for early breast cancer, according to a study published in the International Journal of Radiation Oncology, Biology, Physics. Wesley J. Talcott, MD,...

Women diagnosed with breast cancer who carry germline pathogenic variants (PVs) in BRCA1, BRCA2, CHEK2, and PALB2 have an elevated risk for contralateral breast cancer (CBC), according to a study published in the Journal of...

Plant-based diets are associated with a reduced risk for prostate cancer (PC) progression and recurrence, according to a study presented at the 2023 ASCO Genitourinary Cancers Symposium. Vivian N. Liu and colleagues examined...

Treatment with momelotinib yields clinically significant improvements, when compared with danazol, forpatients with myelofibrosis, according to a study published in The Lancet. Srdan Verstovsek, MD, and colleagues conducted a...